Metabolism of most pharmaceutical drugs occurs in the liver. In drug metabolism, enzymes convert drugs to highly water-soluble metabolites to facilitate excretion from the body. Thus, in vitro models for studying drug metabolism usually target hepatocytes or subcellular liver fractions like microsomes, cytosols, or S9 fractions with high concentrations of specific enzymes. The most popular subcellular fraction used during drug discovery tends to be the microsomes, as these are easy to prepare and store, are amenable to high throughput screening, and are a relatively low-cost option. Understanding the metabolic stability and kinetics of glucuronidation of an investigational drug is crucial for predicting the pharmacokinetic parameters that support dosing and dose frequency. This chapter provides detailed information about metabolite profiling, metabolic stability, glucuronidation kinetics, reactive metabolites identification, CYP enzyme inhibition, and general protocols using human liver microsomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.